REVB Q4 2020 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-2965.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$206,525

Free Cash Flow

-$206,520

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$5M

Total Liabilities

$1M

Stockholders' Equity

$3M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$3,638	-79465.0%
Net Income	-$3M	-$3,638	-79461.5%